ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1834

Commensal Ro60 Autoantigen Ortholog Cross-Reactivity in Human Lupus and Gnotobiotic Models

Teri Greiling1, Carina Dehner2, Stephen Renfroe3, Xinguo Chen4, Kevin Hughes4, Silvio M. Vieira3, William Ruff3, Marco Boccitto4, Andrew Goodman5, Sandra L. Wolin4 and Martin Kriegel3,6, 1Dermatology and Immunobiology, Yale School of Medicine, New Haven, CT, 2Immunobiology, Yale School of Medicine, new haven, CT, 3Immunobiology, Yale School of Medicine, New Haven, CT, 4Cell Biology, Yale School of Medicine, New Haven, CT, 5Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, 6Medicine/Division of Rheumatology, Yale School of Medicine, New Haven, CT

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoantibodies, autoantigens, Lupus, microbiome and molecular mimicry

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The earliest autoantibodies in lupus are directed against the autoantigen Ro60, an RNA binding protein with orthologs that we identified in a subset of skin, oral, and gut commensal species. Thus we hypothesized that commensal Ro60 orthologs may trigger autoimmunity via epitope cross-reactivity in genetically susceptible individuals.

Methods: V4 16S rDNA samples from SLE and control subjects were sequenced using 2x250bp paired-end reads on the Illumina MiSeq platform and also tested for species-specific enrichment for Ro60 bacteria by real-time PCR. Co-immuniprecipitation was performed using human SLE serum and Ro60 ortholog-containing Propionibacterium propionicum and Bacteroides thetaiotaomicron lysates. A northern blot of the resulting RNA was probed for bacterial Y RNA. Memory CD4 T cells from SLE patients were sorted into CCR6+ and CCR6- populations. Ro60-specific T cell clones were isolated and stimulated with heat-killed bacteria. Germ-free mice in gnotobiotic isolators were monocolonized by oral gavage with B. thetaiotaomicron. Serum was tested for anti-Ro60 antibodies by ELISA. Lymphocytes from mesenteric lymph node and spleen were stimulated with recombinant Ro60 and proliferation was assessed using a luminescent cell viability assay.

Results: Ro60-producing oral and gut commensals were prevalent in healthy controls and lupus patients. However, when human serum was used to co-immmunoprecipitate Ro60 and its bound Y RNA from a skin commensal, P. propionicum, only antibodies from human Ro60-positive lupus patients bound commensal Ro60. Lack of reactivity in Ro60-negative patients or healthy controls suggested antibody cross-reactivity between human and commensal Ro60. Next, Ro60 autoantigen-specific CCR6+ and CCR6- CD4 memory T cells clones from lupus patients were isolated and expanded using a T cell library assay. Ro60 T cell clones positive for the tissue-homing marker CCR6 proliferated in response to P. propionicum, demonstrating T cell cross-reactivity with commensal Ro60. Finally, germ-free mice were monocolonized with B. thetaiotaomicron. Mesenteric lymph node and spleen cells from monocolonized mice proliferated in response to bacterial Ro60 and sera contained anti-human Ro60 IgG antibodies.

Conclusion: Ro60 autoimmune T and B cells from human lupus patients reacted with commensal Ro60 in vitro, and commensal Ro60 triggered anti-human Ro60 responses in vivo. Taken together, these data support that colonization with autoantigen ortholog-producing species may induce and sustain chronic autoimmunity in lupus. This concept may apply more broadly to human autoimmune diseases and could lead to development of novel microbiota-targeted approaches to treat autoimmunity.


Disclosure: T. Greiling, None; C. Dehner, None; S. Renfroe, None; X. Chen, None; K. Hughes, None; S. M. Vieira, None; W. Ruff, None; M. Boccitto, None; A. Goodman, None; S. L. Wolin, None; M. Kriegel, None.

To cite this abstract in AMA style:

Greiling T, Dehner C, Renfroe S, Chen X, Hughes K, Vieira SM, Ruff W, Boccitto M, Goodman A, Wolin SL, Kriegel M. Commensal Ro60 Autoantigen Ortholog Cross-Reactivity in Human Lupus and Gnotobiotic Models [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/commensal-ro60-autoantigen-ortholog-cross-reactivity-in-human-lupus-and-gnotobiotic-models/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/commensal-ro60-autoantigen-ortholog-cross-reactivity-in-human-lupus-and-gnotobiotic-models/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology